Achieving incompatible transplantation through desensitization: current perspectives and future directions
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Achieving incompatible transplantation through desensitization: current perspectives and future directions
Authors
Keywords
-
Journal
Immunotherapy
Volume 7, Issue 4, Pages 377-398
Publisher
Future Medicine Ltd
Online
2015-04-28
DOI
10.2217/imt.15.10
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
- (2014) M. Haas et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Quantifying the Risk of Incompatible Kidney Transplantation: A Multicenter Study
- (2014) B. J. Orandi et al. AMERICAN JOURNAL OF TRANSPLANTATION
- U.S. Food and Drug Administration Approval: Obinutuzumab in Combination with Chlorambucil for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia
- (2014) H.-Z. Lee et al. CLINICAL CANCER RESEARCH
- Bortezomib in multiple myeloma: systematic review and clinical considerations
- (2014) T.C. Kouroukis et al. Current Oncology
- Update on the Use of Biologics in Lupus
- (2014) Manisha Relan et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Epratuzumab for systemic lupus erythematosus
- (2014) Sabina Antoniu EXPERT OPINION ON BIOLOGICAL THERAPY
- Anti-CD40-mediated cancer immunotherapy: an update of recent and ongoing clinical trials
- (2014) Sufia Butt Hassan et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Use of Bortezomib as Anti-Humoral Therapy in Kidney Transplantation
- (2014) Keun Suk Yang et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study
- (2014) Jan A Burger et al. LANCET ONCOLOGY
- Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
- (2014) Frits van Rhee et al. LANCET ONCOLOGY
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ofatumumab for Rituximab-Resistant Nephrotic Syndrome
- (2014) Biswanath Basu NEW ENGLAND JOURNAL OF MEDICINE
- Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program
- (2014) Paul Emery et al. PLoS One
- C1-esterase inhibitor treatment: preclinical safety aspects on the potential prothrombotic risk
- (2014) Elmar Raquet et al. THROMBOSIS AND HAEMOSTASIS
- Anti-B cell therapy with rituximab as induction therapy in renal transplantation
- (2014) I. Joosten et al. TRANSPLANT IMMUNOLOGY
- Benefits of Rituximab Combined With Intravenous Immunoglobulin for Desensitization in Kidney Transplant Recipients
- (2014) Ashley A. Vo et al. TRANSPLANTATION
- Eculizumab and Splenectomy as Salvage Therapy for Severe Antibody-Mediated Rejection After HLA–Incompatible Kidney Transplantation
- (2014) Babak J. Orandi et al. TRANSPLANTATION
- Multifunctional CD40L: pro- and anti-neoplastic activity
- (2014) Aleksandra Korniluk et al. TUMOR BIOLOGY
- Ibrutinib for the treatment of mantle cell lymphoma
- (2014) Nimish Shah et al. Expert Review of Hematology
- The Biology and Medical Implications of Interleukin-6
- (2014) T. Tanaka et al. Cancer Immunology Research
- Regulatory B Cells: An Exciting Target for Future Therapeutics in Transplantation
- (2014) Alexandre Nouël et al. Frontiers in Immunology
- Randomized Controlled Pilot Study of B Cell-Targeted Induction Therapy in HLA Sensitized Kidney Transplant Recipients
- (2013) N. S. Ejaz et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Cryptic B Cell Response to Renal Transplantation
- (2013) R. J. Lynch et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Long-Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long-Term Extension of the BENEFIT Study
- (2013) L. Rostaing et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated chronic lymphocytic leukemia (CLL)
- (2013) Tait Shanafelt et al. CANCER
- Persistent Antigen and Germinal Center B Cells Sustain T Follicular Helper Cell Responses and Phenotype
- (2013) Dirk Baumjohann et al. IMMUNITY
- Anti-IL21 receptor monoclonal antibody (ATR-107): Safety, pharmacokinetics, and pharmacodynamic evaluation in healthy volunteers: A phase I, first-in-human study
- (2013) Fei Hua et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Reduced T-Dependent Humoral Immunity in CD20-Deficient Mice
- (2013) D. E. D. Morsy et al. JOURNAL OF IMMUNOLOGY
- Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial
- (2013) Susan O'Brien et al. LANCET ONCOLOGY
- Antibodies to watch in 2014
- (2013) Janice M Reichert mAbs
- Cancer's true breakthroughs
- (2013) Elie Dolgin NATURE MEDICINE
- Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
- (2013) Michael L. Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006
- (2013) V. Strand et al. RHEUMATOLOGY
- Association of high post-transplant soluble CD30 serum levels with chronic allograft nephropathy
- (2013) Patricia C. Grenzi et al. TRANSPLANT IMMUNOLOGY
- B-cell regulation and its application to transplantation
- (2013) Menna R. Clatworthy TRANSPLANT INTERNATIONAL
- Elevated Pretransplantation Soluble BAFF Is Associated With an Increased Risk of Acute Antibody-Mediated Rejection
- (2013) Gemma Banham et al. TRANSPLANTATION
- Efficacy, Outcomes, and Cost-Effectiveness of Desensitization Using IVIG and Rituximab
- (2013) Ashley A. Vo et al. TRANSPLANTATION
- Rituximab Prevents an Anamnestic Response in Patients With Cryptic Sensitization to HLA
- (2013) Andrea A. Zachary et al. TRANSPLANTATION
- Analysis of Anti-HLA Antibodies in Sensitized Kidney Transplant Candidates Subjected to Desensitization with Intravenous Immunoglobulin and Rituximab
- (2013) Andrew L. Lobashevsky et al. TRANSPLANTATION
- The Emerging Role of TH17 Cells in Organ Transplantation
- (2013) Jeremy A. Sullivan et al. TRANSPLANTATION
- Future agents and treatment directions in multiple myeloma
- (2013) Enrique M Ocio et al. Expert Review of Hematology
- Desensitization Offers Hope to Highly HLA-Sensitized Patients for a Longer Life Expectancy After Incompatible Kidney Transplant
- (2012) Stanley C. Jordan et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma
- (2012) R. A. de Claro et al. CLINICAL CANCER RESEARCH
- Targeting Interleukin-6: All the Way to Treat Autoimmune and Inflammatory Diseases
- (2012) Toshio Tanaka et al. International Journal of Biological Sciences
- Bruton Tyrosine Kinase (BTK) and Its Role in B-cell Malignancy
- (2012) Joseph J. Buggy et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
- (2012) Anas Younes et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting B-Cell Receptor Signaling for Anticancer Therapy: The Bruton's Tyrosine Kinase Inhibitor Ibrutinib Induces Impressive Responses in B-Cell Malignancies
- (2012) Adrian Wiestner JOURNAL OF CLINICAL ONCOLOGY
- Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies
- (2012) Ranjana H. Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
- (2012) Tom A. Barr et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia
- (2012) John C. Byrd et al. LEUKEMIA & LYMPHOMA
- The impact of donor-specific anti-HLA antibodies on late kidney allograft failure
- (2012) Alexandre Loupy et al. Nature Reviews Nephrology
- Thrombotic Events Associated with C1 Esterase Inhibitor Products in Patients with Hereditary Angioedema: Investigation from the United States Food and Drug Administration Adverse Event Reporting System Database
- (2012) Pranav K. Gandhi et al. PHARMACOTHERAPY
- Proteasome inhibition by bortezomib: Effect on HLA-antibody levels and specificity in sensitized patients awaiting renal allograft transplantation
- (2012) Martina Guthoff et al. TRANSPLANT IMMUNOLOGY
- Lack of Effect in Desensitization With Intravenous Immunoglobulin and Rituximab in Highly Sensitized Patients
- (2012) Kwaku Marfo et al. TRANSPLANTATION
- Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity
- (2012) Henrik E Mei et al. ARTHRITIS RESEARCH & THERAPY
- Chronic Antibody-Mediated Rejection Is Reduced by Targeting B-Cell Immunity During an Introductory Period
- (2011) N. Kohei et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Clinical Aspects of Intravenous Immunoglobulin Use in Solid Organ Transplant Recipients
- (2011) S. C. Jordan et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A Novel Pathway of Chronic Allograft Rejection Mediated by NK Cells and Alloantibody
- (2011) T. Hirohashi et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Critical Role of Proinflammatory Cytokine IL-6 in Allograft Rejection and Tolerance
- (2011) X. Zhao et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Summary of FDA Antibody-Mediated Rejection Workshop
- (2011) P. Archdeacon et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Impact of IL-6 receptor inhibition on human memory B cells in vivo: impaired somatic hypermutation in preswitch memory B cells and modulation of mutational targeting in memory B cells
- (2011) K. Muhammad et al. ANNALS OF THE RHEUMATIC DISEASES
- B-cell receptor signaling in chronic lymphocytic leukemia
- (2011) F. K. Stevenson et al. BLOOD
- Monitoring and Managing Graft Health in the Kidney Transplant Recipient
- (2011) M. A. Josephson Clinical Journal of the American Society of Nephrology
- Desensitization Protocols and Their Outcome
- (2011) K. Marfo et al. Clinical Journal of the American Society of Nephrology
- B-cell immunotherapeutics
- (2011) Stanley C. Jordan et al. Current Opinion in Organ Transplantation
- Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation
- (2011) Stanley C Jordan et al. Expert Review of Clinical Immunology
- Blockade of IL-6-signaling inhibits the pathogenesis of CD4+ T cell-mediated lethal graft-versus-host reaction against minor histocompatibility antigen
- (2011) Daisuke Noguchi et al. IMMUNOLOGY LETTERS
- IL-6 Promotes Cardiac Graft Rejection Mediated by CD4+ Cells
- (2011) A. J. Booth et al. JOURNAL OF IMMUNOLOGY
- Neutralizing IL-6 Reduces Human Arterial Allograft Rejection by Allowing Emergence of CD161+ CD4+ Regulatory T Cells
- (2011) B. Fogal et al. JOURNAL OF IMMUNOLOGY
- Desensitization in HLA-Incompatible Kidney Recipients and Survival
- (2011) Robert A. Montgomery et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic alloantibody mediated rejection
- (2011) R. Neal Smith et al. SEMINARS IN IMMUNOLOGY
- Pretransplant IgG Subclasses of Donor-Specific Human Leukocyte Antigen Antibodies and Development of Antibody-Mediated Rejection
- (2011) Gideon Hönger et al. TRANSPLANTATION
- Grand Challenges in B cell Biology
- (2011) Thomas L. Rothstein Frontiers in Immunology
- An Integrated View of Molecular Changes, Histopathology and Outcomes in Kidney Transplants
- (2010) P. F. Halloran et al. AMERICAN JOURNAL OF TRANSPLANTATION
- NK Cell Transcripts and NK Cells in Kidney Biopsies from Patients with Donor-Specific Antibodies: Evidence for NK Cell Involvement in Antibody-Mediated Rejection
- (2010) L. G. Hidalgo et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study
- (2010) Gabor G. Illei et al. ARTHRITIS AND RHEUMATISM
- B-cell targeted therapies in human autoimmune diseases: an updated perspective
- (2010) Michael J. Townsend et al. IMMUNOLOGICAL REVIEWS
- Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors
- (2010) M. de Weers et al. JOURNAL OF IMMUNOLOGY
- Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
- (2010) C. Lefaucheur et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Veltuzumab (humanized anti-CD20 monoclonal antibody): characterization, current clinical results, and future prospects
- (2010) David M. Goldenberg et al. LEUKEMIA & LYMPHOMA
- Advances in diagnosing and managing antibody-mediated rejection
- (2010) Stanley C. Jordan et al. PEDIATRIC NEPHROLOGY
- The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
- (2010) L. A. Honigberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Desensitization: achieving immune detente
- (2010) A. A. Zachary et al. TISSUE ANTIGENS
- Combined Posttransplant Prophylactic IVIg/Anti-CD 20/Plasmapheresis in Kidney Recipients With Preformed Donor-Specific Antibodies: A Pilot Study
- (2010) Alexandre Loupy et al. TRANSPLANTATION
- Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney Transplantation
- (2010) Ashley A. Vo et al. TRANSPLANTATION
- De NovoDonor-Specific Antibody at the Time of Kidney Transplant Biopsy Associates with Microvascular Pathology and Late Graft Failure
- (2009) L. G. Hidalgo et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Identifying Specific Causes of Kidney Allograft Loss
- (2009) Z. M. El-Zoghby et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders
- (2009) M. C. Levesque CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- CD20 deficiency in humans results in impaired T cell–independent antibody responses
- (2009) Taco W. Kuijpers et al. JOURNAL OF CLINICAL INVESTIGATION
- B-cell-directed therapies for autoimmune disease
- (2009) Thomas Dörner et al. Nature Reviews Rheumatology
- The Use of Immunoglobulin Therapy for Patients Undergoing Solid Organ Transplantation: An Evidence-Based Practice Guideline
- (2009) Nadine Shehata et al. TRANSFUSION MEDICINE REVIEWS
- Intravenous Immunoglobulin a Natural Regulator of Immunity and Inflammation
- (2009) Stanley C. Jordan et al. TRANSPLANTATION
- The Spectrum of Antibody-Mediated Renal Allograft Injury: Implications for Treatment
- (2008) J. Gloor et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Reducing Antibody Levels in Patients Undergoing Transplantation
- (2008) Ron Shapiro NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation
- (2008) Ashley A. Vo et al. NEW ENGLAND JOURNAL OF MEDICINE
- IdeS: A Bacterial Proteolytic Enzyme with Therapeutic Potential
- (2008) Björn P. Johansson et al. PLoS One
- Acceptable Donor-Specific Antibody Levels Allowing for Successful Deceased and Living Donor Kidney Transplantation After Desensitization Therapy
- (2008) Nancy L. Reinsmoen et al. TRANSPLANTATION
- Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection
- (2008) Matthew J. Everly et al. TRANSPLANTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now